Complete Remission of Methotrexate-Related Epstein-Barr-Virus-Associated Hodgkin-Like Lymphoma following Withdrawal of MTX Coupled with Clarithromycin Administration

<table>Imaging test results: the coronal PET image (upper left) shows wide spread pathological uptake of radiotracer (FDG) in cervical, supraclavicular, mediastinal, para-aortic, peri-iliac and inguinal lymph nodes and spleen. A second PET/CT scan performed 2 months after admission (upper right) shows complete resolution of the abnormal FDG activity. Fused PET/CT image on admission (lower left) shows moderate FDG uptake in the spleen.</table>

Case Reports in Hematology

fig1

Figure 1

Figure 1: Complete Remission of Methotrexate-Related Epstein-Barr-Virus-Associated Hodgkin-Like Lymphoma following Withdrawal of MTX Coupled with Clarithromycin Administration 

Figure 1 | Complete Remission of Methotrexate-Related Epstein-Barr-Virus-Associated Hodgkin-Like Lymphoma following Withdrawal of MTX Coupled with Clarithromycin Administration 